CompoAtlas

Macérât glycériné de bourgeons de Séquoïa

Food supplement declared in France, decision dated 4 August 2025

Macérât glycériné de bourgeons de Séquoïa (La réserve de l’écureuil) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Sequoiadendron giganteum 0.225 g per day. None of the rules we check flags an issue with its declared composition.

Brand
La réserve de l’écureuil
Food business operator placing the product on the market
Colonges Kelly
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
Entre 6 à 30 gouttes
Not recommended (according to the manufacturer)
Pregnant women

Declaration 337695, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Sequoiadendron giganteum (Lindl.) J.BuchholzJeune pousseMacérât hydroglycériné0.225 g

Additives

E422

Other ingredients

Alcool éthylique

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : La réserve de l’écureuil

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Macérât glycériné de bourgeons de Séquoïa (La réserve de l’écureuil): composition and regulation”, https://compoatlas.com/en/supplements/products/337695-macerat-glycerine-de-bourgeons-de-sequoia, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line